SCHEMBL2484432

SCHEMBL2484432

COC(=O)c1nc(-c2cccnc2)cnc1N

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ATR Q13535 20/20 0.67
CYP3A4 P08684 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3462566 0.87 ATR (0.66) ATRCYP3A4
SCHEMBL3462644 0.85 ATR (0.71) ATRCYP3A4
SCHEMBL20433206 0.84 ATR (0.67) ATRCYP3A4
SCHEMBL2486385 0.84 ATR (0.70) ATRCYP3A4
SCHEMBL2484993 0.83 ATR (0.73) ATRCYP3A4
SCHEMBL23389767 0.82 ATR (0.57) ATR
SCHEMBL19672699 0.81 ATR (0.62) ATRCYP3A4
SCHEMBL23389810 0.81 ATR (0.67) ATR
SCHEMBL2482344 0.81 ATR (1.00) ATRCYP3A4
SCHEMBL2483634 0.80 ATR (1.00) ATRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3684184-B1 HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRAZINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2023-06-21 EP claimed
US-20220144801-A1 HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRAZINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2022-05-12 US claimed
US-11229205-B2 Herbicidally active pyridyl-/pyrimidyl-pyrazine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2022-01-25 US claimed
US-20200267984-A1 Herbicidally Active Pyridyl-/Pyrimidyl-Pyrazine Derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-08-27 US claimed
EP-3684184-A1 HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRAZINE DERIVATIVES Syngenta Participations AG (CH) 2020-07-29 EP claimed
CN-111372456-A Herbicidally active pyridyl-/pyrimidinyl-pyrazine derivatives 先正达参股股份有限公司 2020-07-03 CN claimed
WO-2019057723-A1 HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRAZINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-03-28 WO claimed
EP-3684184-B1 HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRAZINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2023-06-21 EP disclosed
US-20230030414-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED 2023-02-02 US disclosed
US-20230030414-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED 2023-02-02 US disclosed
CN-111372456-B Herbicidally active pyridyl-/pyrimidinyl-pyrazine derivatives 先正达参股股份有限公司 2022-10-18 CN disclosed
EP-4059932-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2022-09-21 EP disclosed
EP-4059932-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2022-09-21 EP disclosed
US-8841308-B2 Pyrazin-2-amines useful as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-09-23 US disclosed
EP-2376485-A1 PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2011-10-19 EP disclosed
US-20100222318-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-09-02 US disclosed
US-20100222318-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-09-02 US disclosed
US-20100222318-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-09-02 US disclosed
WO-2010071837-A1 PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-24 WO disclosed
WO-2010071837-A1 PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222318-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE ATR, CHEK1, MAP3K5 ATR 1/4885CYP3A4 4141/4885
US-20230030414-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE ATR, CHEK1, MAP3K5 ATR 1/4885CYP3A4 4141/4885
US-20200267984-A1 Herbicidally Active Pyridyl-/Pyrimidyl-Pyrazine Derivatives DDT, HPD, PLPBP ATR 2054/4885CYP3A4 636/4885
US-20220144801-A1 HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRAZINE DERIVATIVES DDT, HPD, PLPBP ATR 2054/4885CYP3A4 636/4885
US-11229205-B2 Herbicidally active pyridyl-/pyrimidyl-pyrazine derivatives DDT, HPD, PLPBP ATR 2054/4885CYP3A4 636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.